Your session is about to expire
← Back to Search
MAC Therapy for Anxiety in Cancer Patients
N/A
Waitlist Available
Led By Kelly Trevino, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (1-2 weeks after enrollment) and follow-up (7-9 weeks after baseline)
Awards & highlights
Summary
This trial is testing a new therapy to help manage anxiety in cancer patients and their caregivers. The therapy is different from usual care because it uses a plan that has been shown to work in previous studies. This study includes people 65 years of age and older.
Who is the study for?
This trial is for older adults (65+) with certain types of cancer and their caregivers, who live in New York or can attend sessions there. Participants must speak English well, be able to consent, and use the phone for sessions. At least one member of each patient-caregiver pair should have noticeable anxiety. Exclusions include suicidal thoughts, severe weakness or cognitive impairment, recent cognitive-behavioral therapy, schizophrenia, substance issues, bipolar disorder or pregnancy in caregivers.
What is being tested?
The MAC intervention is being tested against usual care to see if it better manages anxiety in older adults with cancer and their caregivers. MAC includes a proven plan tailored for those aged 65+ and involves primary caregivers to enhance support.
What are the potential side effects?
Since this trial tests a psychological therapy rather than medication, traditional side effects are not expected. However participants may experience emotional discomfort discussing personal topics during therapy sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (1-2 weeks after enrollment) and follow-up (7-9 weeks after baseline)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (1-2 weeks after enrollment) and follow-up (7-9 weeks after baseline)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety sub-scale of the Hospital Anxiety and Depression Scale
Hamilton Anxiety Rating Scale
Secondary study objectives
Caregiver Quality of Life-Cancer (caregivers only)
Depression sub-scale of the Hospital Anxiety and Depression Scale
Distress Thermometer
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Managing Anxiety from Cancer (MAC)Experimental Treatment1 Intervention
Older adults with cancer and their primary informal caregiver will receive a seven-session cognitive-behavior therapy intervention administered over the telephone by a trained study interventionist. The intervention is administered weekly and each session is 45-50 minutes in length. Patients and caregivers will receive the intervention independently and from separate therapists.
Group II: Usual CareActive Control1 Intervention
Older adults with cancer and their primary informal caregiver will receive standard care provided by their medical team. These participants will not receive any intervention from the research team.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Managing Anxiety from Cancer (MAC)
2016
N/A
~50
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,977 Total Patients Enrolled
14 Trials studying Anxiety
3,280 Patients Enrolled for Anxiety
Weill Medical College of Cornell UniversityOTHER
1,077 Previous Clinical Trials
1,320,641 Total Patients Enrolled
8 Trials studying Anxiety
292 Patients Enrolled for Anxiety
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,956 Previous Clinical Trials
595,530 Total Patients Enrolled
1 Trials studying Anxiety
50 Patients Enrolled for Anxiety
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- If you have a caregiver, at least one of you reports feeling very anxious on a test called the Hospital Anxiety and Depression Scale (HADS).I have undergone cognitive-behavioral therapy since my cancer diagnosis.You agree to have your voice recorded during assessments and study sessions if needed.I have been diagnosed with a specific type of cancer and am currently undergoing treatment or have completed treatment within the last six months.My doctor agrees I can physically and mentally participate in the study.I am 65 years old or older.I am capable of understanding and giving informed consent.You have someone who takes care of you and is willing to participate in the study.I am too weak or have cognitive issues to participate in the study.I have had thoughts of harming myself recently.I am currently pregnant.I have undergone cognitive-behavioral therapy since my cancer diagnosis.I am the main person providing unpaid support to a cancer patient.I speak English very well.You currently live in New York or can attend sessions in New York.I can talk on the phone for appointments.I am a patient seeking treatment.I am 21 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Managing Anxiety from Cancer (MAC)
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger